Cost Effectiveness of Cardiac Resynchronization Therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial

Koelling TM, Chen RS, Lubwama RN, L’Italien GJ, Eagle KA. The expanding national burden of heart failure in the United States: the influence of heart failure in women. Available at: http://www.medscape.com/viewarticle/466729?src=search. Accessed January 15, 2005. Shamim, 1999, Intraventricular conduction delay, Int J Cardiol, 70, 171, 10.1016/S0167-5273(99)00077-7 Baldasseroni, 2002, Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5,517 outpatients with congestive heart failure, Am Heart J, 143, 398, 10.1067/mhj.2002.121264 Werling, 2002, Biventricular pacing in patients with ICD, Thorac Cardiovasc Surg, 50, 67, 10.1055/s-2002-26702 Nelson, 2000, Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block, Circulation, 102, 3053, 10.1161/01.CIR.102.25.3053 Sogaard, 2001, Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure, Cardiology, 95, 173, 10.1159/000047369 Kawaguchi, 2002, Quantitation of basal dyssynchrony and acute resynchronization from left or biventricular pacing by novel echo-contrast variability imaging, J Am Coll Cardiol, 39, 2052, 10.1016/S0735-1097(02)01883-1 Abraham, 2002, Cardiac resynchronization in chronic heart failure, N Engl J Med, 346, 1845, 10.1056/NEJMoa013168 Linde, 2002, Long-term benefits of biventricular pacing in congestive heart failure, J Am Coll Cardiol, 40, 111, 10.1016/S0735-1097(02)01932-0 Auricchio, 2002, Long-term effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay, J Am Coll Cardiol, 39, 2026, 10.1016/S0735-1097(02)01895-8 Higgins, 2003, Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias, J Am Coll Cardiol, 42, 1454, 10.1016/S0735-1097(03)01042-8 Saxon, 2002, Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling, Circulation, 105, 1304, 10.1161/hc1102.105730 Sogaard, 2002, Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy, J Am Coll Cardiol, 40, 723, 10.1016/S0735-1097(02)02010-7 St. John Sutton, 2003, Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure, Circulation, 107, 1985, 10.1161/01.CIR.0000065226.24159.E9 Bristow, 2004, Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350;, 2140, 10.1056/NEJMoa032423 Technology Evaluation Center (TEC). Special report: cost-effectiveness of implantable cardioverter defibrillators in a MADIT-II population. Available at: http://www.bcbs.com/tec/vol19/19_03.html. Accessed November 3, 2004. Havranek, 1999, Patient preferences for heart failure treatment, J Card Fail, 5, 85, 10.1016/S1071-9164(99)90030-1 Fryback, 1993, The Beaver Dam Health Outcomes Study, Med Decis Making, 13, 80, 10.1177/0272989X9301300202 Tengs, 2000, One thousand health-related quality-of-life estimates, Med Care, 38, 583, 10.1097/00005650-200006000-00004 Sonnenberg, 1993, Markov models in medical decision making, Med Decis Making, 13, 322, 10.1177/0272989X9301300409 Stanton, 2000, Economic outcomes of implantable cardioverter defibrillators, Circulation, 101, 1067, 10.1161/01.CIR.101.9.1067 SCD-HeFT cost-effectiveness called “reasonable” for life-years gained. Medscape CRM News 2004. Available at: http://www.medscape.com/viewarticle/494145. Accessed December 20, 2004. Hlatky, 2004, Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease, Circulation, 110, 1960, 10.1161/01.CIR.0000143379.26342.5C Cleland, 1998, Therapeutic options and cost considerations in the treatment of ischemic heart disease, Cardiovasc Drugs Ther, 12, 225, 10.1023/A:1007765723962 Mushlin, 1998, The cost-effectiveness of automatic implantable cardioverter defibrillators, Circulation, 97, 2129, 10.1161/01.CIR.97.21.2129 Calkins, 2000, Cost-effectiveness of catheter ablation in patients with ventricular tachycardia, Circulation, 101, 280, 10.1161/01.CIR.101.3.280 Mark, 1995, Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction, N Engl J Med, 332, 1418, 10.1056/NEJM199505253322106 Nichol, 2004, Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure, Ann Intern Med, 141, 343, 10.7326/0003-4819-141-5-200409070-00102 McAlister, 2004, Systematic review, Ann Intern Med, 141, 381, 10.7326/0003-4819-141-5-200409070-00101 Torrance, 1996, Framing and designing the cost-effectiveness analysis, 54 Mark, 2002, Medical economics and the assessment of value in cardiovascular medicine, Circulation, 106, 516, 10.1161/01.CIR.0000021407.93752.7B MEDTAP International, Inc. The Value of Investment in Health Care http://www.medtap.com/Products/policy.cfm. Accessed February 10, 2005.